Russia Develops Dengue Fever Vaccine as Clinical Trials Begin

Russia has developed a recombinant genetically engineered vaccine against dengue fever, and its clinical trials are now beginning, according to Veronika Skvortsova, head of the Federal Medical-Biological Agency (FMBA). "A recombinant genetically engineered vaccine against dengue fever has been developed, and its clinical trials are beginning,” she stated at a meeting of the FMBA. The agency head уточнила that the vaccine was created following a request from the President of the Republic of Nicaragua, Daniel Ortega.